1
|
Systematic Review of Tumor Segmentation Strategies for Bone Metastases. Cancers (Basel) 2023; 15:cancers15061750. [PMID: 36980636 PMCID: PMC10046265 DOI: 10.3390/cancers15061750] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 03/09/2023] [Accepted: 03/10/2023] [Indexed: 03/18/2023] Open
Abstract
Purpose: To investigate the segmentation approaches for bone metastases in differentiating benign from malignant bone lesions and characterizing malignant bone lesions. Method: The literature search was conducted in Scopus, PubMed, IEEE and MedLine, and Web of Science electronic databases following the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A total of 77 original articles, 24 review articles, and 1 comparison paper published between January 2010 and March 2022 were included in the review. Results: The results showed that most studies used neural network-based approaches (58.44%) and CT-based imaging (50.65%) out of 77 original articles. However, the review highlights the lack of a gold standard for tumor boundaries and the need for manual correction of the segmentation output, which largely explains the absence of clinical translation studies. Moreover, only 19 studies (24.67%) specifically mentioned the feasibility of their proposed methods for use in clinical practice. Conclusion: Development of tumor segmentation techniques that combine anatomical information and metabolic activities is encouraging despite not having an optimal tumor segmentation method for all applications or can compensate for all the difficulties built into data limitations.
Collapse
|
2
|
Kao YS, Huang CP, Tsai WW, Yang J. A systematic review for using deep learning in bone scan classification. Clin Transl Imaging 2023. [DOI: 10.1007/s40336-023-00539-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
3
|
Lin Q, Gao R, Luo M, Wang H, Cao Y, Man Z, Wang R. Semi-supervised segmentation of metastasis lesions in bone scan images. Front Mol Biosci 2022; 9:956720. [DOI: 10.3389/fmolb.2022.956720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Accepted: 10/13/2022] [Indexed: 11/13/2022] Open
Abstract
To develop a deep image segmentation model that automatically identifies and delineates lesions of skeletal metastasis in bone scan images, facilitating clinical diagnosis of lung cancer–caused bone metastasis by nuclear medicine physicians. A semi-supervised segmentation model is proposed, comprising the feature extraction subtask and pixel classification subtask. During the feature extraction stage, cascaded layers which include the dilated residual convolution, inception connection, and feature aggregation learn the hierarchal representations of low-resolution bone scan images. During the pixel classification stage, each pixel is first classified into categories in a semi-supervised manner, and the boundary of pixels belonging to an individual lesion is then delineated using a closed curve. Experimental evaluation conducted on 2,280 augmented samples (112 original images) demonstrates that the proposed model performs well for automated segmentation of metastasis lesions, with a score of 0.692 for DSC if the model is trained using 37% of the labeled samples. The self-defined semi-supervised segmentation model can be utilized as an automated clinical tool to detect and delineate metastasis lesions in bone scan images, using only a few manually labeled image samples. Nuclear medicine physicians need only attend to those segmented lesions while ignoring the background when they diagnose bone metastasis using low-resolution images. More images of patients from multiple centers are typically needed to further improve the scalability and performance of the model via mitigating the impacts of variability in size, shape, and intensity of bone metastasis lesions.
Collapse
|